Carrollton-based Gradalis, Inc., a clinical-stage biotechnology company developing personalized anti-cancer therapies, has named Steven D. Weinstein as its new chief executive officer. Weinstein brings more than 20 years as a …
Tag:
Carrollton-based Gradalis, Inc., a clinical-stage biotechnology company developing personalized anti-cancer therapies, has named Steven D. Weinstein as its new chief executive officer. Weinstein brings more than 20 years as a …
The Dallas Regional Chamber's Economic Development team serves as a single point of contact for companies, site selection consultants and corporate real estate executives examining the region for new and expanding companies.